Beam Therapeutics Inc. Acquisitions, Net of Cash Acquired
Beam Therapeutics Inc. (BEAM) reported Acquisitions, Net of Cash Acquired of $78.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-02-24
- Beam Therapeutics Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $0.00.
- Beam Therapeutics Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2024-12-31 was $0.00.
- Beam Therapeutics Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2021-03-31 was -$620.00K.
- Beam Therapeutics Inc. payments to acquire businesses, net of cash acquired for fiscal 2025 was $78.00K.
- Beam Therapeutics Inc. payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00.
- Beam Therapeutics Inc. payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $78.00K 10-K · filed 2026-02-24 | |
| 2025-09-30 | $78.00K 10-Q · filed 2025-11-04 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-04 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-24 | ||
| 2021-03-31 | -$620.00K 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |